tiprankstipranks
Trending News
More News >
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market

Ascendis Pharma (ASND) Technical Analysis

Compare
593 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Ascendis Pharma’s (ASND) Moving Averages Convergence Divergence (MACD) indicator is 3.25, suggesting Ascendis Pharma is a Buy.
Ascendis Pharma’s (ASND) 20-Day exponential moving average is 169.59, while Ascendis Pharma’s (ASND) share price is $170.71, making it a Buy.
Ascendis Pharma’s (ASND) 50-Day exponential moving average is 163.80, while Ascendis Pharma’s (ASND) share price is $170.71, making it a Buy.

Ascendis Pharma (ASND) Pivot Points

Jun 21, 2025, 02:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
164.36
168.35
170.63
174.62
176.90
180.89
183.17
Fibonacci
168.35
170.75
172.23
174.62
177.02
178.50
180.89
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascendis Pharma (ASND) Moving Averages

Jun 21, 2025, 02:23 AM
Period
Simple
Exponential
MA5
172.61Sell
172.48Sell
MA10
173.09Sell
171.96Sell
MA20
168.89Buy
169.59Buy
MA50
162.80Buy
163.80Buy
MA100
154.55Buy
156.68Buy
MA200
143.44Buy
147.19Buy
Ascendis Pharma’s (ASND) 10-Day exponential moving average is 171.96, while Ascendis Pharma’s (ASND) share price is $170.71, making it a Sell.
Ascendis Pharma’s (ASND) 100-Day exponential moving average is 156.68, while Ascendis Pharma’s (ASND) share price is $170.71, making it a Buy.
Ascendis Pharma’s (ASND) stock price is $170.71 and Ascendis Pharma’s (ASND) 50-day simple moving average is 162.80, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $170.71 and Ascendis Pharma’s (ASND) 100-day simple moving average is 154.55, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $170.71 and Ascendis Pharma’s (ASND) 200-day simple moving average is 143.44, creating a Buy signal.

Ascendis Pharma (ASND) Technical Indicators

Jun 21, 2025, 02:23 AM
Name
Value
Implied Action
RSI (14)
53.49
Neutral
STOCH (9,6)
51.91
Neutral
STOCHRSI (14)
69.99
Neutral
MACD (12,26)
3.25
Buy
ADX (14)
16.89
Buy
Williams %R
-52.02
Buy
CCI (14)
37.59
Neutral
ATR (14)
6.57
-
Ultimate Oscillator
44.09
Neutral
ROC
4.37
Buy
Ascendis Pharma’s (ASND) Relative Strength Index (RSI) is 53.49, creating a Neutral signal.
Ascendis Pharma’s (ASND) Trend Strength Indicator (ADX) is 16.89, creating a Buy signal.
Ascendis Pharma’s (ASND) Commodity Channel Index (CCI) is 37.59, creating a Neutral signal.
Ascendis Pharma’s (ASND) Price Rate of Change (ROC) is 4.37, creating a Buy signal.

FAQ

Is ASND a Buy, Hold, or Sell?
Based on ASND’s technical indicators, ASND is a Buy.
    What is ASND’s RSI (14)?
    ASND’s RSI (14) is 53.49, which suggests ASND is a Neutral.
      What is ASND’s MACD?
      ASND’s MACD is 3.25, which suggests ASND is a Buy.
        What is ASND’s 5-day moving average?
        ASND’s 5-day moving average is 172.61, which suggests ASND is a Sell.
          What is ASND’s 20-day moving average?
          ASND 20-day moving average is 168.89, which suggests ASND is a Buy.
            What is ASND’s 50-day moving average?
            ASND’s 50-day moving average is 162.80, which suggests ASND is a Buy.
              What is ASND’s 200-day moving average?
              ASND’s 200-day moving average is 143.44, which suggests ASND is a Buy.
                What is ASND’s Williams % R (14)?
                ASND’s Williams % R (14) is -52.02, which suggests ASND is a Buy.
                  What is ASND’s CCI (14)?
                  ASND’s CCI (14) is 37.59, which suggests ASND is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis